Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune‐checkpoint inhibitors

Immune‐related adverse events (irAEs) are often seen during immune‐checkpoint inhibitor (ICI) treatment of various malignancies. Endocrine irAEs including thyroid dysfunctions are the most common irAEs, but their biomarkers remain unclear. In order to identify individuals who are susceptible to thyr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurimoto, Chiaki, Inaba, Hidefumi, Ariyasu, Hiroyuki, Iwakura, Hiroshi, Ueda, Yoko, Uraki, Shinsuke, Takeshima, Ken, Furukawa, Yasushi, Morita, Shuhei, Yamamoto, Yuki, Yamashita, Shimpei, Katsuda, Masahiro, Hayata, Atsushi, Akamatsu, Hiroaki, Jinnin, Masatoshi, Hara, Isao, Yamaue, Hiroki, Akamizu, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226278/
https://www.ncbi.nlm.nih.gov/pubmed/32086984
http://dx.doi.org/10.1111/cas.14363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226278/
https://www.ncbi.nlm.nih.gov/pubmed/32086984
http://dx.doi.org/10.1111/cas.14363

Ejemplares similares